tirzepatide which class is a first-in-class dual agonist targeting both GIP and GLP-1 receptors, offering a powerful and synergistic approach to glycaemic control and weight management., By acting on multiple Switching from Semaglutide to Tirzepatide:

Second, it raises the question of where the ceiling lies, and whether further receptor additions (such as amylin or FGF21 agonism, both under investigation in combination compounds) will continue the upward trend

Zepbound , approved by the FDA in November 2023, focuses on chronic weight management for adults with a BMI of 30 kg/m or higher (classified as obesity) or a BMI of 27 kg/m or higher (classified as overweight) who also have at least one weight-related health condition

"Overall, there are many risks in relation to alcohol use, including severe liver problems," says Johnson-Rabbett

DEREK MUNRO: If youre doing that, sport

One study found that people who slowly reduced their semaglutide dose maintained a stable weight for 26 weeks

Dietary modifications represent the cornerstone of gastroparesis management, as recommended by the British Society of Gastroenterology and NHS guidance: Small, frequent meals : Consuming 56 smaller meals throughout the day rather than three large meals reduces gastric distension and facilitates emptying Low-fat diet : Fats delay gastric emptying